We aim to better dissociate the roles of the left and right DLPFC in cognitive control and spatial processing, using a commonly used saccadic eye-movement task. Future studies will then have better information with regards to the influence of brain…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Neuroscience research (basic science)
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The differences in eye movement behaviours (e.g., reaction times, error
rates,and saccade amplitudes) depending on TMS site
Secondary outcome
Effect of time on primary outcome measures
Background summary
The dorsolateral prefrontal cortex (DLPFC) is important to cognitive and
spatial control, such that one key function of the DLPFC is thought to be the
inhibition against distracting information in order to guide attention to
another location in space. In a typical laboratory task to assess this
function, the anti-saccade task, subjects must look away from a visual stimulus
and generate an accurate eye-movement to another location. It is thought that
the DLPFC is crucial to inhibiting a reflexive eye-movement towards the
stimulus, and generating the voluntary anti-saccade. However, whether each
hemisphere (left/right) contributes similarly to these functions, whether each
hemisphere processes predominantly one side of space, or whether there are
distinct lateralizations (where only one hemisphere is critical) needs to be
assessed. This is important, because the DLPFC is a brain region investigated
in many brain stimulation studies of cognitive control, attention, and spatial
memory processes, but researchers typically only examine the influence of brain
stimulation on left or right DLPFC, but not both.
Study objective
We aim to better dissociate the roles of the left and right DLPFC in cognitive
control and spatial processing, using a commonly used saccadic eye-movement
task. Future studies will then have better information with regards to the
influence of brain stimulation on left or right DLPFC.
Study design
A counter-balanced design, where we will apply 40s of inhibitory transcranial
magnetic stimulation (continuous theta-burst stimulation) cTBS to the right or
left DLPFC (or vertex control region) prior to performing the task.
Intervention
Single-pulse transcranial magnetic stimulation (TMS) and continuous theta burst
stimulation (cTBS).
Study burden and risks
Each participant will receive no direct benefit from participating in the
study, but will receive a compensatory (financial) incentive. Transcranial
magnetic stimulation (TMS) is a widely used non-invasive brain stimulation
technique, based on the principle of electromagnetic induction. During
stimulation the participant will likely hear the clicks of the TMS pulses and
experience stimulation of nerves and muscles of the head. The most common side
effect is a light transient headache (2-4% occurrence). A severe headache is
uncommon (0.3-0.5% occurrence). In TMS studies of patient populations (e.g.
epilepsy) or that exceeded the standard protocols (e.g. in intensity or
frequency) epileptic seizures have been reported in rare cases. In the current
study all participants will be stimulated with protocols that fall within the
safety guidelines. All subjects are screened for their relevant medical history
and other TMS safety aspects (e.g. presence of metal parts in the head). In
summary, because the risk and burden associated with participation can be
considered negligible-to-minimal, we do not expect serious adverse events
during the project.
Kapittelweg 29
Nijmegen 6525 EN
NL
Kapittelweg 29
Nijmegen 6525 EN
NL
Listed location countries
Age
Inclusion criteria
• Healthy
• Between 18-30 years of age years;
• Right-handed;
• Normal or corrected-to-normal vision (no glasses);
• Willingness and ability to give written informed consent and ability to
understand the nature and content of the study to participate and to comply with the study
requirements.
Exclusion criteria
Large or ferromagnetic metal parts in the head
Skin diseases at intended electrode sites (EMG, EEG, tDCS/tACS)
History of epilepsy or seizure (or familial history)
Any exclusion as per TMS screening form
History or current presence of any neurological, psychological or psychiatric disorder (e.g., depression)
Any prescribed medication that can alter cortical excitability (e.g. antiepileptics, tricyclic anti-depressives or benzodiazepines) or can have an influence on the participant*s vigilance or cognitive performance within two weeks prior to participation
Pregnancy
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL59958.091.17 |